Skip to main content

ADVERTISEMENT

Julie Gould

Raj Toleti, chief executive officer and founder of Andor Health
Interview
08/12/2021
Raj Toleti, chief executive officer and founder of Andor Health, discusses the future of telehealth with a focus on how technological advances will encourage patient follow-up, ease administrative burden for providers, and keep patient data...
Raj Toleti, chief executive officer and founder of Andor Health, discusses the future of telehealth with a focus on how technological advances will encourage patient follow-up, ease administrative burden for providers, and keep patient data...
Raj Toleti, chief executive...
08/12/2021
Integrated Healthcare Executive
Charlotte Owens, MD, FACOG, therapeutic area lead, women's health, US medical affairs, AbbVie
Interview
08/10/2021
In this interview, Charlotte Owens, MD, FACOG, former therapeutic area lead, women's health, US medical affairs, AbbVie, explains the impact of endometriosis and uterine fibroids, reviews data from the American College of Obstetricians and...
In this interview, Charlotte Owens, MD, FACOG, former therapeutic area lead, women's health, US medical affairs, AbbVie, explains the impact of endometriosis and uterine fibroids, reviews data from the American College of Obstetricians and...
In this interview, Charlotte...
08/10/2021
Population Health
John D’Amore, cofounder, board member, and strategic advisor for Diameter Health, and Laura McCrary, EdD, president and CEO of KONZA
Interview
08/09/2021
John D’Amore, cofounder, board member, and strategic advisor for Diameter Health, and Laura McCrary, EdD, president and CEO of KONZA, explain the differences in how ambulatory quality calculations vary when using data from a single electronic...
John D’Amore, cofounder, board member, and strategic advisor for Diameter Health, and Laura McCrary, EdD, president and CEO of KONZA, explain the differences in how ambulatory quality calculations vary when using data from a single electronic...
John D’Amore, cofounder, board...
08/09/2021
First Report Managed Care
Michael Werner, PhD, scientific director of oncology for US medical affairs, AbbVie
Interview
08/09/2021
Michael Werner, PhD, scientific director of oncology for US medical affairs, AbbVie, discusses recent study findings presented at ASCO 2021, highlighting the efficacy of venetoclax for the treatment of acute myeloid leukemia.
Michael Werner, PhD, scientific director of oncology for US medical affairs, AbbVie, discusses recent study findings presented at ASCO 2021, highlighting the efficacy of venetoclax for the treatment of acute myeloid leukemia.
Michael Werner, PhD, scientific...
08/09/2021
Population Health
Headshot of Eric Tichy on a blue background underneath the PopHealth Perspectives logo.
Podcasts
08/09/2021
Eric Tichy, PharmD, MBA, vice chair, Mayo Clinic, discusses a Mayo Clinic report on drug spending during the COVID-19 pandemic, highlighting which drugs saw dramatic increases or decreases in spending, as well as how providers can use...
Eric Tichy, PharmD, MBA, vice chair, Mayo Clinic, discusses a Mayo Clinic report on drug spending during the COVID-19 pandemic, highlighting which drugs saw dramatic increases or decreases in spending, as well as how providers can use...
Eric Tichy, PharmD, MBA, vice...
08/09/2021
Pharmacy Learning Network
Chris Beyrer, MD, infectious disease epidemiologist and professor at Johns Hopkins Bloomberg School of Public Health
Podcasts
08/06/2021
Chris Beyrer, MD, infectious disease epidemiologist and professor at Johns Hopkins Bloomberg School of Public Health, discusses fundamental barriers within HIV care, and how the US health system can better manage the HIV epidemic, which...
Chris Beyrer, MD, infectious disease epidemiologist and professor at Johns Hopkins Bloomberg School of Public Health, discusses fundamental barriers within HIV care, and how the US health system can better manage the HIV epidemic, which...
Chris Beyrer, MD, infectious...
08/06/2021
First Report Managed Care
News
08/06/2021
“Patients with AD are more likely to be diagnosed with HS than patients without AD. Further research is needed to understand the pathophysiologic mechanism and potential treatment implications,” wrote researchers.
“Patients with AD are more likely to be diagnosed with HS than patients without AD. Further research is needed to understand the pathophysiologic mechanism and potential treatment implications,” wrote researchers.
“Patients with AD are more...
08/06/2021
First Report Managed Care
News
07/27/2021
According to recent study findings, phototherapy-related costs are not adequately considered in treatment recommendations and often vary among skin diseases.
According to recent study findings, phototherapy-related costs are not adequately considered in treatment recommendations and often vary among skin diseases.
According to recent study...
07/27/2021
First Report Managed Care
Conference Insider
07/23/2021
In a session at Great Debates and Updates Oncology Pharmacy, Val Adams PharmD, FCCP, FHOPA, BCOP, breaks down guideline-directed molecular testing recommendations for non-small cell lung cancer (NSCLC) as well as current challenges facing...
In a session at Great Debates and Updates Oncology Pharmacy, Val Adams PharmD, FCCP, FHOPA, BCOP, breaks down guideline-directed molecular testing recommendations for non-small cell lung cancer (NSCLC) as well as current challenges facing...
In a session at Great Debates...
07/23/2021
Pharmacy Learning Network
Conference Insider
07/22/2021
In a session at Great Debates & Updates Oncology Pharmacy, Kirollos Hanna, PharmD, BCPS, BCOP, provides pharmacist-guided decisions that should be implemented for treatment selections among patients with CLL/SLL, and reviews strategies for...
In a session at Great Debates & Updates Oncology Pharmacy, Kirollos Hanna, PharmD, BCPS, BCOP, provides pharmacist-guided decisions that should be implemented for treatment selections among patients with CLL/SLL, and reviews strategies for...
In a session at Great Debates &...
07/22/2021
Pharmacy Learning Network